Publications by authors named "Edward Ottley"

Claim this Profile
R
Real-world evidence study on the early use of cemiplimab in the UK: REACT-CEMI (Real World evidence of advanced CSCC treatment with cemiplimab).
Amarnath Challapalli, Grant Stewart, Heather Shaw, Peter John Davies, Juan Carlos Lopez-Baez, Edward C Ottley

Front Immunol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Greater utility of molecular subtype rather than epithelial-to-mesenchymal transition (EMT) markers for prognosis in high-risk non-muscle-invasive (HGT1) bladder cancer.
Edward C Ottley, Robert Pell, Benedict Brazier, Julianne Hollidge, Christiana Kartsonaki

J Pathol Clin Res· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Over-Expression of Activin-β Is Associated with Murine and Human Prostate Disease.
Edward C Ottley, Karen L Reader, Kailun Lee, Francesco E Marino, Helen D Nicholson

Horm Cancer· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activin A regulates microRNAs and gene expression in LNCaP cells.
Edward Christopher Ottley, Helen Diana Nicholson, Elspeth Joan Gold

Prostate· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
microRNA and non-canonical TGF-β signalling: implications for prostate cancer therapy.
Edward Ottley, Elspeth Gold

Crit Rev Oncol Hematol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insensitivity to the growth inhibitory effects of activin A: an acquired capability in prostate cancer progression.
Edward Ottley, Elspeth Gold

Cytokine Growth Factor Rev· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis